Literature DB >> 18956209

Changes in estrogen receptor-alpha variant (ER-alpha36) expression during mouse ovary development and oocyte meiotic maturation.

Bao-Zeng Xu1, Sheng-Li Lin, Mo Li, Jia-Qiao Zhu, Sen Li, Ying-Chun Ouyang, Da-Yuan Chen, Qing-Yuan Sun.   

Abstract

The biological effects of estrogens are largely mediated through estrogen receptors (ERs), which belong to the nuclear receptor gene family of transcription factors. ER-alpha36 has been recently identified as a new variant of ERalpha, but its expression and roles in female reproduction system remain unknown. Immunocytochemistry and confocal microscopy were employed to observe ER-alpha36 distribution in mouse ovary during postnatal development and in oocyte during meiotic maturation. ER-alpha36 was consistently present in the nuclei of oocytes regardless of follicular growth stage and mouse age until germinal vesicle breakdown (GVBD). Its immunosignal was smeared in granulosa cells. However, the ER-alpha36 signal is up-regulated and found in cytoplasm with little or no nuclear staining during corpus luteum development. ER-alpha36 was also found in theca cells. We showed by Western blot that ER-alpha36 was expressed in mouse oocytes at various maturation stages. When the function of nuclear ER-alpha36 was blocked by microinjecting anti-ER-alpha36 specific antibody into the germinal vesicle (GV) of mouse oocytes, the first polar body emission occurred earlier in a higher proportion of oocytes compared to the control. These results suggest that ER-alpha36 may play critical roles in mouse ovarian folliculogenesis and oocyte development.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18956209     DOI: 10.1007/s00418-008-0526-4

Source DB:  PubMed          Journal:  Histochem Cell Biol        ISSN: 0948-6143            Impact factor:   4.304


  41 in total

1.  Immunohistochemical localization of estrogen receptors in the ovine corpus luteum throughout the estrous cycle.

Authors:  D Zieba; B Bilińska; B Schmalz-Fraczek; M Murawski
Journal:  Folia Histochem Cytobiol       Date:  2000       Impact factor: 1.698

2.  Tissue distribution and quantitative analysis of estrogen receptor-alpha (ERalpha) and estrogen receptor-beta (ERbeta) messenger ribonucleic acid in the wild-type and ERalpha-knockout mouse.

Authors:  J F Couse; J Lindzey; K Grandien; J A Gustafsson; K S Korach
Journal:  Endocrinology       Date:  1997-11       Impact factor: 4.736

3.  Gonadotropin induction of ovulation and corpus luteum formation in young estrogen receptor-alpha knockout mice.

Authors:  C S Rosenfeld; A A Murray; G Simmer; M G Hufford; M F Smith; N Spears; D B Lubahn
Journal:  Biol Reprod       Date:  2000-03       Impact factor: 4.285

4.  Prevention of the polycystic ovarian phenotype and characterization of ovulatory capacity in the estrogen receptor-alpha knockout mouse.

Authors:  J F Couse; D O Bunch; J Lindzey; D W Schomberg; K S Korach
Journal:  Endocrinology       Date:  1999-12       Impact factor: 4.736

Review 5.  Translational regulation in development.

Authors:  D Curtis; R Lehmann; P D Zamore
Journal:  Cell       Date:  1995-04-21       Impact factor: 41.582

6.  Expression of estrogen receptor alpha mRNA and protein variants in human endometrial carcinoma.

Authors:  O Jazaeri; M A Shupnik; A A Jazaeri; L W Rice
Journal:  Gynecol Oncol       Date:  1999-07       Impact factor: 5.482

7.  Comparative analysis of protein synthesis, transcription and cytoplasmic polyadenylation of mRNA during maturation of bovine oocytes in vitro.

Authors:  W Tomek; H Torner; W Kanitz
Journal:  Reprod Domest Anim       Date:  2002-04       Impact factor: 2.005

8.  Age-associated increase in aneuploidy and changes in gene expression in mouse eggs.

Authors:  Hua Pan; Pengpeng Ma; Wenting Zhu; Richard M Schultz
Journal:  Dev Biol       Date:  2008-02-15       Impact factor: 3.582

Review 9.  Estrogen receptor alpha: impact of ligands on intracellular shuttling and turnover rate in breast cancer cells.

Authors:  Guy Leclercq; Marc Lacroix; Ioanna Laïos; Guy Laurent
Journal:  Curr Cancer Drug Targets       Date:  2006-02       Impact factor: 3.428

Review 10.  The steroid and thyroid hormone receptor superfamily.

Authors:  R M Evans
Journal:  Science       Date:  1988-05-13       Impact factor: 47.728

View more
  5 in total

Review 1.  Extending the knowledge in histochemistry and cell biology.

Authors:  Wolfgang-Moritz Heupel; Detlev Drenckhahn
Journal:  Histochem Cell Biol       Date:  2009-11-28       Impact factor: 4.304

2.  Estrogen receptor α36 mediates a bone-sparing effect of 17β-estrodiol in postmenopausal women.

Authors:  Hui Xie; Mei Sun; Xiao-Bo Liao; Ling-Qing Yuan; Zhi-Feng Sheng; Ji-Cai Meng; Dan Wang; Zhi-Yong Yu; Lei-Yi Zhang; Hou-De Zhou; Xiang-Hang Luo; Hui Li; Xian-Ping Wu; Qi-You Wei; Si-Yuan Tang; Zhao-Yi Wang; Er-Yuan Liao
Journal:  J Bone Miner Res       Date:  2011-01       Impact factor: 6.741

3.  ER-α36 mediates cisplatin resistance in breast cancer cells through EGFR/HER-2/ERK signaling pathway.

Authors:  Linlin Zhu; Jiao Zou; Yuanyin Zhao; Xiaomei Jiang; Yang Wang; Xiangwei Wang; Bin Chen
Journal:  J Exp Clin Cancer Res       Date:  2018-06-25

4.  Expression of estrogen receptor α 36 (ESR36) in the hamster ovary throughout the estrous cycle: effects of gonadotropins.

Authors:  Prabuddha Chakraborty; Shyamal K Roy
Journal:  PLoS One       Date:  2013-03-29       Impact factor: 3.240

Review 5.  ER-α36: a novel biomarker and potential therapeutic target in breast cancer.

Authors:  Xingyun Su; Xin Xu; Guangliang Li; Bingyi Lin; Jiang Cao; Lisong Teng
Journal:  Onco Targets Ther       Date:  2014-08-30       Impact factor: 4.147

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.